Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.

CONCLUSION: Major bleeding events were not uncommon during prolonged anticoagulation therapy in real-world VTE patients. Active cancer, previous major bleeding, anemia, thrombocytopenia, and old age were the independent risk factors for major bleeding. PMID: 31230344 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31230344?dopt=Abstract

Source: Thrombosis and Haemostasis - June 22, 2019 Category: Hematology Authors: Kim K, Yamashita Y, Morimoto T, Kitai T, Yamane T, Ehara N, Kinoshita M, Kaji S, Amano H, Takase T, Hiramori S, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi Tags: Thromb Haemost Source Type: research